Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Check with your insurance provider about coverage for approved weight loss treatments
Phentermine raises heart rate and blood pressure, while semaglutide affects cardiovascular regulation through different mechanisms, creating unpredictable cardiovascular stress
CagriSema submitted for FDA approval in December 2025 with expected approval in Q4 2026 or Q1 2027, meaning launch around mid-2027
Retatrutide may improve metabolism through its multi-receptor action, which affects not only appetite regulation but also insulin sensitivity and other metabolic processes
In case of overdose, call the poison control helpline at 1-800-222-1222
US$ 22.93
US$ 24.62
US$ 29.18
US$ 28.30
US$ 28.43
US$ 22.72
US$ 28.51
US$ 22.89
US$ 28.99
US$ 28.76
US$ 25.72
US$ 29.69
